Madrigal Pharmaceuticals, Inc. (MDGL)

559.93 -11.51 (-2.01%) USD  |  NASDAQ  |  Dec 15, 16:00
550.00 -9.93 (-1.77%) After-Hours: 16:49
More

Madrigal Pharmaceuticals Price to CFO Per Share (TTM)

Price to CFO Per Share (TTM) Chart

View Price to CFO Per Share (TTM) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to CFO Per Share (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to CFO Per Share (TTM) Range, Past 5 Years

View Price to CFO Per Share (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to CFO Per Share (TTM) Benchmarks

View Price to CFO Per Share (TTM) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Insmed, Inc. --
Ionis Pharmaceuticals, Inc. --